Author

Helen S. Pentikis

Observed names: H PENTIKIS, H. Pentikis, H. S. Pentikis, H.S. Pentikis, HELEN S. PENTIKIS, Helen Pentikis, Helen S Pentikis, Helen Stamidis Pentikis, Pentikis, Helen S.

Observed institutions: University of Maryland, Baltimore, Pharmaceutical Product Development (United States), United States Food and Drug Administration, Center for Drug Evaluation and Research, Johns Hopkins University, Icon (United States), Biopure (United States), ICON PLC (Ireland), Salix Pharmaceuticals (United States), Symbiomix Therapeutics (United States)

ORCID: 0009-0001-7544-0540

Observed ORCID: 0009-0001-7544-0540

OpenAlex ID: A5025358448

Methylphenidate bioavailability from two extended-release formulations

2002 · M.A. González, H.S. Pentikis, et al. · International Journal of Clinical Pharmacology and Therapeutics · 77

Effect of Albumin on the Estimation, In Vitro, of Phenytoin Vmax and Km Values: Implications for Clinical Correlation

1997 · Linda K. Ludden, Thomas M. Ludden, et al. · Journal of Pharmacology and Experimental Therapeutics · 57

Influence of hepatic impairment on lenvatinib pharmacokinetics following single‐dose oral administration

2014 · Robert Shumaker, Jagadeesh Aluri, et al. · The Journal of Clinical Pharmacology · 56

PDF

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin®, in resistant solid tumor malignancies

2008 · Paula M. Fracasso, Joel Picus, et al. · Cancer Chemotherapy and Pharmacology · 52

The Effect of Multiple‐Dose, Oral Rifaximin on the Pharmacokinetics of Intravenous and Oral Midazolam in Healthy Volunteers

2007 · Helen S. Pentikis, Margaret Connolly, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 42

Co‐administration of ketoconazole with H1‐antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects

2005 · P. Chaikin, M. S. Gillen, et al. · British Journal of Clinical Pharmacology · 42

PDF

Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis

2009 · J.S. Barrett, E. Gibiansky, et al. · International Journal of Clinical Pharmacology and Therapeutics · 41

Methylphenidate Bioavailability in Adults When an Extended-Release Multiparticulate Formulation Is Administered Sprinkled on Food or as an Intact Capsule

2002 · HELEN S. PENTIKIS, ROY D. SIMMONS, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 40

PDF

Absence of Effect of Oral Rifaximin on the Pharmacokinetics of Ethinyl Estradiol/Norgestimate in Healthy Females

2007 · Carol Braun Trapnell, Margaret Connolly, et al. · Annals of Pharmacotherapy · 39

Pharmacokinetics and Safety of FV-100, a Novel Oral Anti-Herpes Zoster Nucleoside Analogue, Administered in Single and Multiple Doses to Healthy Young Adult and Elderly Adult Volunteers

2011 · Helen S. Pentikis, Mark Matson, et al. · Antimicrobial Agents and Chemotherapy · 38

Bioequivalence: Individual and Population Compartmental Modeling Compared to the Noncompartmental Approach

1996 · Helen S. Pentikis, James D. Henderson, et al. · Pharmaceutical Research · 25

A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias

2019 · Tara L. Lin, Laura F. Newell, et al. · Cancer Chemotherapy and Pharmacology · 19

PDF

Ambrisentan Has No Clinically Relevant Effect on the Pharmacokinetics or Pharmacodynamics of Warfarin

2006 · Michael J. Gerber, Christopher Dufton, et al. · CHEST Journal · 19

An Evaluation of the Pharmacokinetics and Pharmacodynamics of the Histrelin Implant for the Palliative Treatment of Prostate Cancer

2005 · Martin K. Dineen, David S. Tierney, et al. · The Journal of Clinical Pharmacology · 17

Pharmacological In Vivo Inhibition of S-Nitrosoglutathione Reductase Attenuates Bleomycin-Induced Inflammation and Fibrosis

2015 · Irina G. Luzina, Virginia Lockatell, et al. · Journal of Pharmacology and Experimental Therapeutics · 16

CPX-351 ((Cytarabine:Daunorubicin) Liposome Injection, (Vyxeos)) Does Not Prolong Qtcf Intervals, Requires No Dose Adjustment for Impaired Renal Function and Induces High Rates of Complete Remission in Acute Myeloid Leukemia

2015 · Tara L. Lin, Laura F. Newell, et al. · Blood · 12

460 a Study of the Safety and Pharmacokinetics of Single Ascending Oral Doses of Inx-08189, a Nucleotide Polymerase Inhibitor, in Healthy Subjects

2011 · J. Patti, M. Matson, et al. · Journal of Hepatology · 12

PDF

An Integrated Efficacy and Safety Analysis of Single-Dose Secnidazole 2 g in the Treatment of Bacterial Vaginosis

2020 · Helen Pentikis, Nikki Adetoro, et al. · Reproductive Sciences · 11

PDF

The exposure-response relationship of niraparib in patients with gBRCAmut and non-gBRCAmut: Results from the ENGOT-OV16/NOVA Trial

2017 · J. Wang, Z-Y. Zhang, et al. · Annals of Oncology · 11

Lack of a Pharmacokinetic Interaction Between SYM-1219 Granules Containing 2 Grams of Secnidazole and a Combined Oral Contraceptive in a Phase 1, Randomized, Open-Label Study in Healthy Female Volunteers

2016 · Helen S. Pentikis, Nikki Adetoro, et al. · Advances in Therapy · 10

Two Phase 1, Open‐Label, Single‐Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions

2017 · Helen S. Pentikis, Nikki Adetoro · Clinical Pharmacology in Drug Development · 8

PDF

The Effect of Food on the Bioavailability of Ebastine

1997 · Helen Stamidis Pentikis, Mei-Ying Huang, et al. · American Journal of Therapeutics · 8

Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals

2017 · Borje Darpo, Hongqi Xue, et al. · The Journal of Clinical Pharmacology · 6

PDF

16: A phase 3 randomized, double-blind, placebo-controlled study to confirm the efficacy and safety of a single, oral dose of SYM-1219, a granule formulation containing 2 grams of secnidazole, for the treatment of bacterial vaginosis

2016 · J. Schwebke, F. Morgan, et al. · American Journal of Obstetrics and Gynecology · 5

Population Pharmacokinetics of Telbivudine and Determination of Dose Adjustment for Patients With Renal Impairment

2009 · Xiao‐Jian Zhou, June Ke, et al. · The Journal of Clinical Pharmacology · 5

Works count: 46

Citation count: 696

H-index: 15

I10-index: 20